| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/08/2006 | EP1623711A1 External patch containing estrogen and/or progestogen |
| 02/08/2006 | EP1623710A1 Receptor antagonist |
| 02/08/2006 | EP1623705A1 Use of phenylethanolaminotetralines for preparing anxiolytic drugs |
| 02/08/2006 | EP1623703A1 Controlled release hydrocodone formulations |
| 02/08/2006 | EP1623230A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39) |
| 02/08/2006 | EP1622914A2 New piperidinylamino-thieno 2,3-d pyrimidine compounds |
| 02/08/2006 | EP1622912A2 2-ALKYNYL-AND 2-ALKENYL-PYRAZOLO- [4,3-E] -1,2,4-TRIAZOLO- [1,5-C] -PYRIMIDINE ADENOSINE A sb 2A /sb RECEPTOR ANTAGONISTS |
| 02/08/2006 | EP1622911A2 Pyrrolo[1,2-b]pyridazine compounds and their use as crf-1 receptor antagonists |
| 02/08/2006 | EP1622910A1 Fused pyrimidine derivatives with crf activity |
| 02/08/2006 | EP1622884A1 New heterocyclic amides exhibiting an inhibitory activity at the vanilloid receptor 1 (vr1). |
| 02/08/2006 | EP1622881A1 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having parp enzyme inhibitory effect |
| 02/08/2006 | EP1622874A1 Quinolone derivatives |
| 02/08/2006 | EP1622871A1 Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 02/08/2006 | EP1622868A1 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives |
| 02/08/2006 | EP1622640A1 Glutamate receptor antagonists as neuroprotectives |
| 02/08/2006 | EP1622637A2 Method and compositions for nerve regeneration |
| 02/08/2006 | EP1622636A2 Use of intraputaminal infused glial cell-line derived neurotrophic factor in the treatment of parkinson's disease in humans |
| 02/08/2006 | EP1622631A2 Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic-pituitary-adrenal axis over-activity |
| 02/08/2006 | EP1622625A1 Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo [5.2.o] non-1 (7)-en-2-yl )alkyl] phosphonic acid and derivatives and methods of use thereof |
| 02/08/2006 | EP1622614A2 Use of a topical medicament comprising riluzole |
| 02/08/2006 | EP1622609A2 Methods for treating degenerative diseases/injuries |
| 02/08/2006 | EP1622598A2 Regulation of guanine nucleotide exchange factor |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1423168B1 Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | EP1297006B1 Regulation of human prostasin-like serine protease |
| 02/08/2006 | EP1257278B1 The use of mirtazapine for the treatment of sleep disorders |
| 02/08/2006 | EP1235776B1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 02/08/2006 | EP1187815B1 4-phenyl-pyrimidine derivatives |
| 02/08/2006 | EP1183243B1 Short-acting benzodiazepines |
| 02/08/2006 | EP1112362B1 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 02/08/2006 | EP1088104B1 Methods for treating a neurological disease by determining bche genotype |
| 02/08/2006 | EP0932600B1 Sulfonamide substituted aspartic acid interleukin-1beta converting enzyme inhibitors |
| 02/08/2006 | EP0812318B1 4-aminotetrahydrobenzisoxazole or -isothiazole compounds |
| 02/08/2006 | CN1732259A Method of degrading hardly degradable protein |
| 02/08/2006 | CN1732182A Peptides and medicinal compositions containing the same |
| 02/08/2006 | CN1732162A 1,2,4-triaminobenzenderivater nyttige for behandling AV forstyrrelser i sentralnervesystemet |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732005A Use of istradefylline (kw-6002) for the treatment of behavioral disorders |
| 02/08/2006 | CN1731999A Benzothiazole derivatives |
| 02/08/2006 | CN1731991A The use of sussinate derivative esters for the treatment of dementia |
| 02/08/2006 | CN1730494A Cobratide modified by polyethylene glycol, its preparation method and uses |
| 02/08/2006 | CN1730095A Tranquilization and brain enriching drop pill and process for preparing the same |
| 02/08/2006 | CN1730087A Wind dispelling drop pill containing amomum fruit and process for preparing the same |
| 02/08/2006 | CN1730069A Anti- paralysis capsule |
| 02/08/2006 | CN1730062A Chinese medicinal composition for invigorating spleen, tonifying kidney, relieving metal stress and its preparation process |
| 02/08/2006 | CN1729980A Dripping pills of tetrahydropalmatini sulfas and its preparation process |
| 02/08/2006 | CN1729976A Drug for treating function disorder of autonomic nervous system |
| 02/08/2006 | CN1729971A Health caring formulation for treating insomnia |
| 02/08/2006 | CN1729970A Black-white formulation for treating insomnia |
| 02/08/2006 | CN1240836C Transforming growth factor alpha HI |
| 02/08/2006 | CN1240716C Pituitary adenylate cyclase activated polypeptide derivatives and process for preparing the same |
| 02/08/2006 | CN1240701C 2,3,4,4-tetrahydro-1H-pyrazino (1,2-a) quinoxalin-5(6H) one deivatives being 5HT2C agonists |
| 02/08/2006 | CN1240691C Substituted penta azacylo compounds and their use for preventing and treating nervous retrogression disease |
| 02/08/2006 | CN1240677C Monofluoroalkyl derivatives |
| 02/08/2006 | CN1240668C Method for preparing memantine hydrochloride |
| 02/08/2006 | CN1240431C Chinese medicinal extract for dispelling drunk and protecting liver and its preparation method |
| 02/08/2006 | CN1240424C Chinese medicine for treating vascular dementia and its preparation process |
| 02/08/2006 | CN1240405C Oral liquid for treating deuteropathic weak and senile weak |
| 02/08/2006 | CN1240385C Method for preparing nimodipine carrying float sustained release mini capsule |
| 02/08/2006 | CN1240384C Transdermal administration of huperzine |
| 02/08/2006 | CN1240381C Use of 5-hydroxymethyl furfural in preparation of medicine and healthcare product for prevention and treatment of degenerative disease of nervous system and cognize hurt |
| 02/08/2006 | CN1240329C Gold brain-care pillow pad |
| 02/07/2006 | US6995272 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/07/2006 | US6995268 Heterocyclic amines such as 4-(2-(diphenylmethoxy)ethyl)-1-((3-fluorophenyl)methyl)piperidine, used for prophylaxis nervous system disorders, drug abuse and dependence, Parkinson's disease or as antidepressants |
| 02/07/2006 | US6995241 Acute Neuronal Induced Calcium-Binding Protein (ANIC-BP-1B) polypeptides and polynucleotides; diagnostic assays; neuroprotectants; agonists; antagonists; stroke , Parkinson's disease, Alzheimer disease, multiple sclerosis and spinal cord injuries |
| 02/07/2006 | US6995184 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
| 02/07/2006 | US6995182 1-sulfonyl pyrrolidine derivatives |
| 02/07/2006 | US6995176 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/07/2006 | US6995169 Synergistic mixture |
| 02/07/2006 | US6995167 Arylkylamine spirofuropyridines useful in therapy |
| 02/07/2006 | US6995163 having an excellent corticotrophin-releasing-factor receptor antagonistic activity; for treating or preventing depression, nerve system disorders, schizophrenia, peptic ulcer, irritable bowel syndrome |
| 02/07/2006 | US6995161 Central nervous system disorders |
| 02/07/2006 | US6995159 4-piperazin-1-yl-2-(pyridin-2-ylmethoxy)-pyrimidine, 2-(6-methyl-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine, and 2-(6-chloro-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine; for treatment of seizure and eating disorders; reduced side effects |
| 02/07/2006 | US6995155 Imines such as 4-(3-((3-(2,4-dichlorophenyl)propanoyl)amino)-1-(3-(morpholin-4-yl)propyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-5-yl)benzamide, administered for prophylaxis of Alzheimer's disease |
| 02/07/2006 | US6995153 tachykinin receptor antagonist, in particular, an NK1 receptor antagonist; prophylactic or therapeutic agent against tachykinin receptor-related pathological conditions, including increased urinary frequency, incontinence, vomiting, inflammation |
| 02/07/2006 | US6995151 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 02/07/2006 | US6995150 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 02/07/2006 | US6995144 for example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 02/07/2006 | US6995140 Peptides and polypeptides useful for regenerating the nervous system |
| 02/07/2006 | US6994994 Of the tumor necrosis factor receptor family; given amino acid sequence; use treating diseases and disorders ameliorated or cured by decreasing the levels of ligands of the original CD40R such as autoimmune diseases |
| 02/07/2006 | US6994993 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans |
| 02/07/2006 | US6994990 Active modified hedgehog proteins |
| 02/07/2006 | US6994970 Peptides which bind auto-antibodies for use in extracorporeal treatment; peptides bound to solid support for chromatography; specified amino acid sequence |
| 02/07/2006 | US6994959 which compete with DNA-binding sites of regulatory proteins which regulate t-cell activity (CD28 and cytokines), preventing transcription; analyzing immunocompetence; for treatment of autoimmune diseases |
| 02/07/2006 | US6994957 Using nucleic acid |
| 02/07/2006 | US6994873 Modified release granules |
| 02/07/2006 | US6994859 Biologically active, hemagglutinin from type A Clostridium botulinum and methods of use |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | US6994843 Delivery of stimulants through an inhalation route |
| 02/07/2006 | US6994842 Aerogel powder therapeutic agents |
| 02/07/2006 | CA2450111C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 02/07/2006 | CA2360308C Glucocorticoid receptor modulators |
| 02/07/2006 | CA2340202C Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/07/2006 | CA2316082C Substituted 2-benzylamino-2-phenyl-acetamide compounds |
| 02/07/2006 | CA2311344C 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
| 02/07/2006 | CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 02/07/2006 | CA2262454C Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha. |
| 02/07/2006 | CA2135639C Controlled release preparation containing a salt of morphine |
| 02/07/2006 | CA2119783C Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |